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Abstract Exocytosis of secretory granules by adreual chromaffin cells is blocked by the tetanus toxin light chain in a zinc specific manner. Here 
we show that celluJar synaptobrevin is almost completely degraded by the tetanus toxin light chain within 15 min, We used highly purified adrenal 
secretory granule. to show that synaptobrevin, whieh can be eleaved by the tetanus toxin light chain, is localized in the vesieular membrane. Proteolysis 
of synaptobrevin in cells and in secretory granule. is reversibly inhibited by the zine ehelating agent dipicolinie acid. Moreover, cleavage of 
.ynaptobrevin present in secretory granule. by the tetanus toxin light chain i. blocked by the zine peptidase inhibitor captopril and by synaptobrevin 
derived peptides. Our data indicate that the tetanus toxin light ehain acts as a zine dependent protease that cleaves synaptobrevin of secretory granules, 
an essential component of the exocytosis machinery in adrenal chromaffin ceUs. 
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1. Introduction 
Tetanus and botulism are caused by clostridial neurotoxins 
which preferentially block transmitter release from glycinergie 
and eholinergic nerve terminals [I], Recent observations indi-
cate that these neurotoxins attack membrane proteins of synap-
tic vesicles or of the presynaptic plasmalemma which are likely 
components of the dockinglfusion eomplex in nerve endings 
[2-10]. Barlier investigations have shown that clostridial neuro-
toxins also block exocytosis of secretory granules from adrenal 
ehromaffin cells. Indeed the basic mechanisms of the neurotox-
ins' action have first been detected in adrenal chromaffin cells 
[11-18] and have subsequently been eonfirmed in neurons [19-
23]. From these studies it is evident that the neurotoxins aet 
intracellularly, that chain separation is aprerequisite for the 
inhibition of exocytosis by the light ehains of the neurotoxins, 
and that they specifically bloek calcium triggered process(es) 
within the easeade of events leading to exoeytosis. Recently, we 
identified the metal binding motif of the tetanus toxin light 
chain (TeTxL) as a key strueture which mediates inhibition of 
exocytosis in adrenal chrom affin cells specifically when eom-
plexed with zine [24]. Here we report that this action of the 
tetanus toxin light ehain is due to the specific cleavage of syn-
aptobrevin (SB) and identify synaptobrevin as an essential com-
ponent of the exoeytosis maehinery of ehromaffin eells. 
2. Experimental 
2.1. Materials 
2.1.1. Toxins, peptides and chemieals. Tetanus toxin was isolated 
and characterized as previously described [25,26]. During toxin purifi· 
cation EDTA (4 mM) was preseut in the first column step (HIC). 
Tetanus toxin was separated into its heavy and light chains by isoelec-
tric focusing in a sucrose gradient with ampholyte under reducing 
conditions in 2 molll urea [27]. Before use the purified tetanus toxin 
light chain (TeTxL) preparation was dialyzed against potassium gluta-
mate medium (see below). Streptolysin 0, used for controlled permea· 
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bi!ization of the ehromaffin cells [28,29] was purified from group A 
streptococci (Richards strain) by SH-specific chromatography followed 
by HIC ehromatography (Weller et al. unpublished). 
The peptides QFET and ASQFETS were kindly prepared by 
], Neckermann (Ulm, Germany) by solid phase synthesis using an 
automatie synthesizer (43IA, Applied Biosystems, Foster City, 
CA, USA) employing F-moe chemistry. The peptides were detaehed 
with TFA from the resin, analyzed by HPLC on a Pep-S 5 11m column 
(Pharmaeia, Freiburg, Germany) and charaeterized by Edman sequene-
ing (model 473 A sequenzer, Applied Biosystems, Foster City, 
CA, USA), Peptides I (DALQAGASVFESSAAKLKRK) and 2 
(DALQAGASQFETSAAKLKRK) were generous gifts from H. 
Niemann (Tübingen, Germany), Captopril (3·mereapto·2-methylpro-
pionyl·L·proline) was from Bristol-Myers Squibb (München, Ger· 
many). All other chemicals were of analytical grade, 
2.2. Methods 
2.2.1. Cu/rivalion, permeabilization and incubarion of chromaffin cells 
with TeTxL. Bovine adrenal chromaffin cells were isolated and grown 
as deseribed [24] except that the cells were plated at a higher density 
(7 x 10' cells/well). After two days in culture the cells were permeabi!· 
ized (at 30°C for 2 min) witb streptolysin 0 (63 hemolytic units/well) 
in potassium glutamate medium (150 mM potassium glutamate, 10 mM 
PIPES (pH 7.2), 5 mM EDTA, 0.5 mM EGTA) eontaining 2 mM 
Mg'+.ATP, 7.67 mM magnesium acetate, 0.1% BSA and I mM dithio-
threitol [24,29,30]. Tbe medium was then replaced by the same medium 
containing TeTxL and/or the ehernieals to be tested, followed by incu-
bation for 25 min at 30°e. Finally, the cells of each weil were Iyzed with 
100 111 SDS·sample buffer and proteins (determined with the BCA 
method, Pierce, Oud-Beijerland, Netherlands) were prepared for SDS· 
PAGE. 
2.2.2. Isolarion of chromaffin vesiele membranes and incubarion wirh 
TeTxL. Chromaffin vesicles were isolated as described [31,32]. Brietly, 
bovine adrenal glands were perfused with 5 mM HEPES (pH 7.0), 150 
mM NaCl, 5 mM EDTA. Tbe medullae were homogenized in (20% w/v) 
20 mM MOPS (pH 7.0),5 mM EDTA, 340 mM SUCrDse in a Tetlon· 
to-glass homogenizer, From the postnuclear supematant ehromaffin 
vesieles were harvested by centrifugation for 20 min at 12,000 x g. They 
were placed on a discontinuous sucrose gradient coßsisting of 4 ml of 
2.4 M and 2 ml ofeach 2,2, 2,0,1.8 and 1.6 M sucrose in 20 mM MOPS 
(pH 7.0), 5 mM EDTA. Centrifugation was done for 1 hat 40,000 rpm 
in a 50,2 Ti rotor (Beckman). Absorbance at 280 nm after precipitation 
ofthe protein with 10% (w/v) TCA was measured to conveniently locate 
chromaffin vesicles in the gradient while arylsulfatase served to ideutify 
fractions containing lysosomes and other subcellular membranes 
[31,32]. The ehromaffin vesicles were recovered from the gradient, di· 
luted 1:4 with 20 mM MOPS (pH 7.0),5 mM EDTA and centrifuged 
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for I hat 100,000 x g. The purified chromaffin vesieles were osmotically 
Iyzed by addition of a ten-fold exeess of 20 mM MOPS (pH 7.0) with 
5 mM EDTA. Chromaffin vesiele membranes were recovered by cen-
trifugation for I h at 100,000 x g and washed twice in potassium gluta-
mate medium (see above) containing 6 mM magnesium acetate. The 
final pellet was suspended in the same medium and stored at -20·C 
until use. Chromaffin vesiele membranes (100 f.lg) were solubilized with 
0.5 mg of p-D-oetylglucopyranoside and incubated in a volume of 
50 f.ll for 30 min at 300C in potassium glutamate medium (see above) 
containing 20 pmol TeTxL andlor the different ehemicals to be tested. 
The reaction was stopped by cooling on ice, lipids were extracted by 
chloroform/methanol [33] and the sampies were proeessed for SDS-
PAGE. 
2.2.3. Immunob/otting. The sampies of ehromaffin vesiele mem-
branes or of chromaflin cells were separated by SDS-PAGE (12.5%) 
[34] and biotted onto nitrocellulose as described [35]. Binding of the 
monoclonal anti-synaptobrevin antibody (Cl. 10.1; diluted I : 2,000) [36) 
or of the monoelonal anti-synaptotagmin [ antibody (Cl. 41.1; diluted 
I: 2,000) [37) was deteeled in sampies of ehromaffin cells by peroxidase 
labelled anti-mouse [gG antibodies (Dianova, Hamburg) and the en-
hanced chemiluminescence method (Amersham Buchler, Braun-
schweig). For proteins prepared from ehromaffin vesiele membranes, 
biotinylated anti-mouse [gG (Dianova, Hamburg) and avidin labelled 
peroxidase (Vectastain, Burlingame, CA, USA) and deteetion by DAB 
was employed. For controls we used a polyclonal neuron specifie eno-
lase (NSE) antibody (Dako Diagnostika, Hamburg, Gennany). 
3. Results aod discussion 
Blockade of transmitter release from neurons by tetanus 
toxin is paralleled by the cleavage of synaptobrevin, a mem-
brane protein of synaptic vesicles [2,3,6]. Exocytosis of 
hormone containing secretory granules is also inhibited by tet-
anus toxin [12,13,15,16,38]. More recently we established the 
role of zinc and the HELIH motif of the tetanus toxin light 
chain (TeTxL) for the inhibition of calcium induced catechol-
amine release from adrenal chromaffin cells [24]. Here we 
probed the functional significance of synaptobrevin for exocy-
tosis of adrenal chromaffin cells using TeTxL as a tool. 
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Fig. 1. Synaptobrevin cleavage within chromaffin cells by the tetanus 
toxin light ehain as a function of time. After permeabi1ization the cells 
were incubated for 5, 15 or 30 min with 100 nM TeTxL at 30·C. The 
reaction was stopped by addition of SDS-sample buffer, followed by 
immunoblotting and synaptobrevin detection by the enhanced ehemilu-
minescence method. The lower panel shows almost complete disappear-
anee of synaptobrevin (SB) with time of ineubation. The upper panel 
displays the same blot after immunodetection of synaptotagmin (ST), 
demonstrating the same amount, of sampies in all lanes. 
















Fig. 2. Synaptobrevin eleavage within chromaffin cells by the tetanus 
toxin light chain depends on zine. As observed in immunoblots (lower 
panel), ineubation of penneabilized chromaffin cells with 100 nM 
TeTxL resulls in a deerease ofthe synaptobrevin (SB) immunoreactive 
band. Addition of 100 f.lM dipicolinic acid (DPA) or of I mM captopril 
abolished this effect. The activity of TeTxL is restored after addition 
of 100 f.lM Zn>+' The upper panel shows the control with anti-NSE. 
adrenal chromaffin cells. Within 15 min of incubation of perme-
abilized chromaffin cells with TeTxL the synaptobrevin band 
of 18 kOa was greatly diminished and it was barely detectable 
after 30 min (Fig. 1,Iower panel). In contrast, TeTxL treatment 
does not affect the electrophoretic mobility of other compo-
nents of chrom affin cells such as synaptotagmin (ST) (Fig. 1, 
upper panel) or neuron specific enolase (NSE) (Fig. 2, upper 
panel). Moreover, we did not notice a change in the pattern of 
protein bands in Coomassie and silver stained gels of chro-
maffin cells (not shown). Although this does not completely 
rule out that there may be TeTxL targets other than synapto-
brevin [39,40], it is particularly intriguing that the specific 
degradation of synaptobrevin observed here and inhibition of 
exocytosis reported earlier [15,16,24] occured under identical 
conditions. 
Zinc can be removed from the catalytic sile of TeTxL by 
dipicolinic acid (OPA) [41], a chelating agent with high affinity 
for zinc [42]. Concomitantly the inhibiton of secretory granule 
exocytosis by TetxL is abolished [24,41]. We found that synap-
tobrevin cleavage within chromaffin cells is impaired by dipi-
colinic acid (Fig. 2). Moreover, addition of zinc restored the 
activity of TeTxL (Fig. 2). Together these data suggest a causal 
link between zinc dependent cleavage of synaptobrevin by 
TeTxL and inhibition of exocytosis. The zinc peptidase inhibi-
tor captopril and synaptobrevin derived peptides abolish the 
effect of TeTxL on neurotransmitter release and c1eavage of 
synaptobrevin in isolated synaptic vesicles [2,3]. Moreover Ihe 
inhibition of vasopressin release from neurohypophysial nerve 
terminals by TeTxL is blocked by these substances [41]. How-
ever, neither synaptobrevin derived peptides nor captopril 
block the effect of TeTxL on catecholamine release by chro-
maffin cells [24]. One could argue that breakdown of peptides 
and of the peptide derivative captopril by endogenous enzymes 
of chromaffin cells or absence of synaptobrevin from chro-
maffin vesic1e membranes [43,44] could account for these obser-
vations. 
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Fig. 3. Sucrose density gradient fractionation of adrenal chromaffin 
vesieles. Chromaffin vesieles obtained by differential centrifugation 
were further purified on a discontinuous sucrose gradient (see section 
2). The fractions were collected from the bottom of the gradient. Ab-
sorbance at 280 nm oftbe TCA supematant" protein and the Iysosomal 
enzyme arylsulfatase were measured. Chromaffin vesieles, marked by 
a bar, exhibit the highest density while lysosomes and other cantaminat-
ing organelles such as mitochondria [31,32] are found at lower suerose 
densities. Synaptobrevin (immunoblot at bottom) was only found in 
chromaffin vesiele fractions. 
In order to c1arify these issues, we first isolated adrenal chro-
maffin vesicles by differential centrifugation and further puri-
fied them in hyperosmotic suerose gradients (see section 2). 
This procedure yields highly purified chromaffin vesicles with 
negligible contamination by lysosomes and other subcellular 
organelles [31,32]. As revealed by immunoblotting, the ehro-
maffin vesicle fractions of the gradient clearly do contain syn-
aptobrevin (see Fig. 3). We then recovered chromaffin vesicles 
from the suerose gradients, Iyzed them hypotonieally (see sec-
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Fig. 4. Cleavage of synaptobrevin in chromaffin vesiele membranes by 
the tetanus toxin light chain depends on zine. Chromaffin vesiele mem-
branes (100 pg) were incubated for 30 min at 30·C with or witbout 20 
pmol tetanus toxin light ehain (TeTxL). Immunoblots revealed an al-
most camplete disappearance of the synaptobrevin (SB) immunoreae-
tive band. Addition of 400 pmolar dipieolinie aeid (OPA) abolished the 
effeet ofTeTxL. Reactivation ofTeTxL occurred with 400 pmolar zine. 
Captopril (4 mM) prevented the cleavage of synaptobrevin by TeTxL. 
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Fig. 5. Effect of synaptobrevin derived peptides on tbe cleavage of 
synaptobrevin in chromaffin vesiele membranes by Ihe tetanus toxin 
light ehain. Ineubation of chromaffin vesiele membranes (100 pg) with 
20 pmol TeTxL caused an ahnost camplete disappearance of synapto-
brevin analyzed in immunoblots (C, ouly chromaffin vesiele membrans; 
I, witb TeTxL). Peptides (400 IlM) of different lenglh ( 2, QFET; 3, 
ASQFETS; 4, peptide I; 5, peptide 2) carresponding in sequence to Ihe 
cleavage sile of synaplobrevins (see seclion 2) abolished tbe effect of 
TeTxL on synaptobrevin degradation. 
toxin light chain (TeTxL). We first determined whether synap-
tobrevin of chromaffin vesicle membranes is a substrate for 
TeTxL and whether the activity of the neurotoxin is blocked 
by DPA. This chelating agent has been shown to remove zine 
from TeTxL [41], to abolish the inhibition of catecholamine 
release by TeTxL [24] and to block cleavage of synaptobrevin 
in chromaffin cells (see above). We found that TeTxL, within 
30 min of incubation at 30oe, almost eompletely removed im-
munoreactive synaptobrevin from ehromaffin vesicle mem-
branes (Fig. 4). This effect was suppressed by DPA and was 
restored by zine (Fig. 4). Furthermore, we found that the cleav-
age of synaptobrevin by TeTxL was blocked by captopril, an 
inhibitor of zine peptidases (Fig. 4). Finally, peptides spanning 
the site of synaptobrevins cleaved by TeTxL in synaptic vesicles 
[2,3] were tested for an effect on synaptobrevin cleavage in 
chromaffin vesicle membranes. Both of the shorter peptides 
used (QFET and ASQFETS) and longer peptides (20-mers, see 
section 2) corresponding in sequence to synaptobrevin 1 and 
peptide 2 (a synaptobrevin 2 analogue) inhibited the cleavage 
of synaptobrevin in chromaffin vesicle membranes (Fig. 5). 
Taken together our data indieate that TeTxL acts selectively 
as a zine-dependent protease on synaptobrevin present in adre-
nal ehromaffin vesicle membranes. Thus, it ean be eoncluded 
that seeretory granules (this study) and synaptie vesicles [2,3,6], 
the storage organelles of neurotransmitters, neuropeptides and 
hormones, share the target of the tetanus toxin. This target, 
synaptobrevin, together with other membrane proteins and sol-
uble proteins is a central eomponent of a complex, whieh is 
critieal for exocytosis [9,10]. 
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